Literature DB >> 27586800

Bile acids in regulation of inflammation and immunity: friend or foe?

Ci Zhu1, Claudia D Fuchs1, Emina Halilbasic1, Michael Trauner2.   

Abstract

Apart from their pivotal role in dietary lipid absorption and cholesterol homeostasis, bile acids (BAs) are increasingly recognised as important signalling molecules in the regulation of systemic endocrine functions. As such BAs are natural ligands for several nuclear hormone receptors and G-protein-coupled receptors. Through activating various signalling pathways, BAs not only regulate their own synthesis, enterohepatic recirculation and metabolism, but also immune homeostasis. This makes BAs attractive therapeutic agents for managing metabolic and inflammatory liver disorders. Recent experimental and clinical evidence indicates that BAs exert beneficial effects in cholestatic and metabolically driven inflammatory diseases. This review elucidates how different BAs function as pathogenetic factors and potential therapeutic agents for inflammation-driven liver diseases, focusing on their role in regulation of inflammation and immunity.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27586800

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  29 in total

Review 1.  Dietary and metabolic modulators of hepatic immunity.

Authors:  Antonella Carambia; Johannes Herkel
Journal:  Semin Immunopathol       Date:  2017-11-06       Impact factor: 9.623

2.  The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice.

Authors:  Yongqing Wang; Hiroaki Aoki; Jing Yang; Kesong Peng; Runping Liu; Xiaojiaoyang Li; Xiaoyan Qiang; Lixin Sun; Emily C Gurley; Guanhua Lai; Luyong Zhang; Guang Liang; Masayuki Nagahashi; Kazuaki Takabe; William M Pandak; Phillip B Hylemon; Huiping Zhou
Journal:  Hepatology       Date:  2017-04-28       Impact factor: 17.425

Review 3.  Emerging roles of bile acids in mucosal immunity and inflammation.

Authors:  Mei Lan Chen; Kiyoshi Takeda; Mark S Sundrud
Journal:  Mucosal Immunol       Date:  2019-04-05       Impact factor: 7.313

Review 4.  The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.

Authors:  Mehmet Kanbay; Emine M Onal; Baris Afsar; Tuncay Dagel; Aslihan Yerlikaya; Adrian Covic; Nosratola D Vaziri
Journal:  Int Urol Nephrol       Date:  2018-05-04       Impact factor: 2.370

5.  Beyond the antibodies: serum metabolomic profiling of myasthenia gravis.

Authors:  Derrick Blackmore; Zaeem Siddiqi; Liang Li; Nan Wang; Walter Maksymowych
Journal:  Metabolomics       Date:  2019-08-01       Impact factor: 4.290

6.  Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.

Authors:  Dana Tedesco; Manoj Thapa; Chui Yoke Chin; Yong Ge; Minghao Gong; Jing Li; Sanjeev Gumber; Patrick Speck; Elizabeth J Elrod; Eileen M Burd; William H Kitchens; Joseph F Magliocca; Andrew B Adams; David S Weiss; Mansour Mohamadzadeh; Arash Grakoui
Journal:  Gastroenterology       Date:  2018-02-15       Impact factor: 22.682

7.  Sex-related differences in urinary immune-related metabolic profiling of alopecia areata patients.

Authors:  Yu Ra Lee; Haksoon Kim; Bark Lynn Lew; Woo Young Sim; Jeongae Lee; Han Bin Oh; Jongki Hong; Bong Chul Chung
Journal:  Metabolomics       Date:  2020-01-16       Impact factor: 4.290

8.  Metabolomic profile overlap in prototypical autoimmune humoral disease: a comparison of myasthenia gravis and rheumatoid arthritis.

Authors:  Derrick Blackmore; Liang Li; Nan Wang; Walter Maksymowych; Elaine Yacyshyn; Zaeem A Siddiqi
Journal:  Metabolomics       Date:  2020-01-04       Impact factor: 4.290

Review 9.  Adrenal function and dysfunction in critically ill patients.

Authors:  Arno Téblick; Bram Peeters; Lies Langouche; Greet Van den Berghe
Journal:  Nat Rev Endocrinol       Date:  2019-07       Impact factor: 43.330

10.  Bile Acids Elevated in Chronic Periaortitis Could Activate Farnesoid-X-Receptor to Suppress IL-6 Production by Macrophages.

Authors:  Shan Cao; Xinyu Meng; Yixuan Li; Li Sun; Lindi Jiang; Hanqing Xuan; Xiaoxiang Chen
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.